Internal Medicine Department of Integrated Traditional Chinese and Western Medicine, Graduate School, Guangxi University of Chinese Medicine, Nanning, China.
Department of Traditional Chinese Medicine, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Curr Pharm Biotechnol. 2023;24(13):1630-1644. doi: 10.2174/1389201024666230313151316.
The precise treatment of liver cancer is receiving much research attention. Surgery, chemoradiotherapy, and other methods remain the mainstream of this treatment, but many chemotherapeutic drugs used to treat advanced liver cancer cause adverse reactions and have unstable efficiencies. Active ingredients used in traditional Chinese medicine (TCM) have been examined widely in anti-cancer research due to their advantages of multi-pathway targeting and rich pharmacological effects. However, these active components have poor water solubility, bioavailability, and targeting efficiency. Nanomedicine has been applied to improve the efficacy of TCM ingredients in the treatment of liver cancer. Nanoparticles (NPs) show great potential in this context due to their excellent bioavailability, high controlled agent release efficiency, and clear targeting. This paper reviews the application of NPs loaded with active TCM ingredients in the treatment of liver cancer, with the aim of facilitating new vector development and improving the precision treatment of liver cancer.
肝癌的精准治疗受到广泛关注。手术、放化疗等方法仍是治疗的主流,但许多用于治疗晚期肝癌的化疗药物会引起不良反应,且疗效不稳定。由于中药(TCM)的活性成分具有多途径靶向和丰富的药理作用的优点,因此在抗癌研究中得到了广泛的研究。然而,这些活性成分的水溶性、生物利用度和靶向效率较差。纳米医学已被应用于提高中药成分在肝癌治疗中的疗效。由于其出色的生物利用度、高控制药物释放效率和明确的靶向性,纳米颗粒(NPs)在此方面具有很大的潜力。本文综述了负载 TCM 活性成分的 NPs 在治疗肝癌中的应用,旨在促进新载体的开发,提高肝癌的精准治疗水平。